Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution
Tianlong is committed to expanding its presence in Thailand and working closely with local partners to provide excellent…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 May 23
Tianlong is committed to expanding its presence in Thailand and working closely with local partners to provide excellent…
25 May 23
Flowfect Discover is an automated high-throughput gene delivery platform designed to discover and optimise cell therapy and living…
25 May 23
$2.4M contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program supports clinical…
23 May 23
The deal gives the US-based firm access to Oncimmune’s commercialised CE-IVD marked EarlyCDT Lung blood test, autoantibody platform,…
22 May 23
The Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is a molecular diagnostic test that detects and differentiates four of the…
19 May 23
The BD FACSDiscover S8 Cell Sorter is the first BD instrument to feature BD SpectralFX™ Technology and BD…
17 May 23
The new application, BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA), uses AI to automate the task of inspecting Petri…
16 May 23
The Opto B Discovery workflows on the Beacon Select system include advanced technologies and features that help scientists…
15 May 23
The Prosigna assay analyses the activity of the PAM50 gene signature, along with clinical-pathological features, to provide a…
11 May 23
The hospital will be equipped with state-of-the-art diagnostic and therapeutic oncology solutions over the next three years, contributing…